Bristol-Myers Squibb Co. (BMY)


Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Bristol-Myers Squibb Co. chart...

About the Company

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

CEO

Giovanni Caforio

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

https://www.bms.com/

$45B

Total Revenue

34K

Employees

$116B

Market Capitalization

13.67

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BMY News

Is Bristol Myers Squibb Stock a Buy?

on MSN ago, source:

That's the case with biotech giant Bristol Myers Squibb (NYSE: BMY). The drugmaker has seen its shares drop by 22% over the ...

Bristol-Myers Squibb Company (BMY) Impacted by Delay in New Product Launches

3d ago, source: InvestingChannel on MSN

Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2023 investor letter. A ...

Bristol Myers Squibb cuts hundreds of Mirati staffers months after closing $5.8B buyout

1d ago, source: FiercePharma

Two months after closing its multibillion-dollar acquisition of Mirati Therapeutics, Bristol Myers Squibb is bidding adieu to ...

Bristol-Myers Squibb Co

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bristol-Myers Squibb Earnings: BMY Stock Bounces on Strong Q2, Guidance

9d ago, source: AOL

Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.18 for the second quarter of 2019. This is better than the ...

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

2d ago, source:

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United Kingdom ...

Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics

9d ago, source: New Jersey Business

Bristol Myers Squibb (BMS) has successfully completed its acquisition of Karuna Therapeutics, Inc. Through this transaction, ...

Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial

8d ago, source:

Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating ...

Bristol-Myers Squibb Co BMY

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bristol Myers Squibb Completes Acquisition Of Karuna Therapeutics - Quick Facts

10d ago, source:

Bristol Myers Squibb (BMY) has successfully completed its acquisition of Karuna Therapeutics, Inc. Karuna shares have ceased trading ...

Bristol-Myers Squibb Co.

6d ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...